LVTX a possible continuation medical technology penny stock LONGLVTX is a pharmaceutical company focused on biologicals for advanced prostate carcinoma.
It recently secured a collaboration agreement with Merck to assist in the clinical trials and
the financial burdens it imposes in a quid pro quo related to a share of product margins in the
future. On the 1